Elaprase 2 mg/ml concentrate for solution for infusion
DNLI-E-0007
Phase 3 small_molecule active
Quick answer
Elaprase 2 mg/ml concentrate for solution for infusion for Mucopolysaccharidosis Type II [MPS II] is a Phase 3 program (small_molecule) at Denali Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Denali Therapeutics
- Indication
- Mucopolysaccharidosis Type II [MPS II]
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active